Search results
GSK Plunges as Drugmaker Must Face Zantac Cases in Delaware
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- GSK Plc shares plunged in the wake of a court ruling that the UK drugmaker, alongside...
GSK Stock Dips on Delaware Court Ruling for Zantac Litigation
Zacks via Yahoo Finance· 2 days agoGSK shares decline more than 7% in pre-market trading on Monday in response to an unfavorable ruling...
GSK Stock Falls as 70,000 Zantac Lawsuits Move Forward. What to Know.
InvestorPlace· 2 days agoMany investors expected today’s move in GlaxoSmithKline (NYSE:GSK), with shares of GSK stock...
FTSE 100 Live 3 June: New York trading glitch sparks volatility, GSK shares tumble
Evening Standard via Yahoo Finance· 1 day agoGSK shares are today’s major focus after the drugs giant’s defence against Zantac claims suffered a...
GSK shares fall 9% in wake of Zantac court ruling
Pharmaceutical Technology via Yahoo Finance· 1 day agoMonday saw a 9% drop in GlaxoSmithKline’s (GSK) share price on the London Stock Exchange (LSE), following a Delaware judge’s ruling on 31 May that more...
GSK Stock Slumps on Zantac Setback
The Wall Street Journal· 2 days agoGSK shares (UK:GSK, GSK) dropped after a state court in Delaware said it would allow more than 70,000 cases that allege its Zantac heartburn ...
GSK Plc ADR (NYSE: GSK): Performance Review And Forecast – Marketing Sentinel
Marketing Sentinel· 2 days agoIn today’s recent session, 6.61 million shares of the GSK Plc ADR (NYSE:GSK) have been traded, and its beta is 0.67. Most recently the company’s share price ...
Zantac Heart Burn Continues For GSK As US Court Ruling Allows Thousands Of Zantac Lawsuits To Move...
Benzinga via Yahoo Finance· 2 days agoOn Monday, GSK Plc (NYSE:GSK) shares were down after the Delaware State Court ruled that more than...
GSK shares tumble 9% after 70,000 Zantac lawsuits allowed to move forward By Investing.com
Investing.com· 2 days agoShares in British drugmaker GSK fell sharply Monday following a Delaware judge's decision to allow...
GSK reports 100% response in rectal cancer study with Jemperli By Investing.com
Investing.com· 2 days agoGSK plc (LSE/NYSE: LON:GSK) has shared updated results from a phase II study conducted in...